The 106b∼25 microRNA cluster is essential for neovascularization after hindlimb ischaemia in mice

European Heart Journal

Volumn 35, Issue 45, 2014, Pages 3212-3223

  Semo, Jonathan ^a,b   Sharir, Rinat ^a,b   Afek, Arnon ^b   Avivi, Camila ^c   Barshack, Iris ^b,c   Maysel Auslender, Sofia ^a   Krelin, Yakov ^a   Kain, David ^b   Entin Meer, Michal ^a   Keren, Gad ^a   George, Jacob ^d,e  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d KAPLAN MEDICAL CENTER   (Israel)

^e HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Angiogenesis; MicroRNAs

Indexed keywords

CASPASE 3; CD133 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CXCL1 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MICRORNA; MICRORNA 106B; MICRORNA 25; MICRORNA 93; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROLIFERIN; PROTEIN KINASE B; STEM CELL ANTIGEN 1; STROMAL CELL DERIVED FACTOR 1; STROMELYSIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; LY ANTIGEN; LY6A PROTEIN, MOUSE; MEMBRANE PROTEIN; MIRN106 MICRORNA, MOUSE; MIRN25 MICRORNA, MOUSE; PEPTIDE; PTEN PROTEIN, HUMAN; STEM CELL FACTOR RECEPTOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BONE MARROW STROMA CELL; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; FLOW CYTOMETRY; GENE CLUSTER; GENE DELETION; GENE OVEREXPRESSION; HEART INFARCTION; HEART MUSCLE; HINDLIMB; IN SITU HYBRIDIZATION; IN VITRO STUDY; KNOCKOUT MOUSE; LASER DOPPLER PERFUSION IMAGING; LIMB BLOOD FLOW; LIMB ISCHEMIA; MOUSE; MOUSE MODEL; NEOVASCULARIZATION (PATHOLOGY); NEURAL STEM CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCINTIGRAPHY; TRANSIENT TRANSFECTION; VASCULAR RING; ANGIOGENESIS; ANIMAL; AORTA; BLOOD FLOW VELOCITY; BONE MARROW CELL; CELL MOTION; CELL SURVIVAL; ISCHEMIA; METABOLISM; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PHYSIOLOGY; STROMA CELL; VASCULARIZATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, LY; AORTA; APOPTOSIS; BLOOD FLOW VELOCITY; BONE MARROW CELLS; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; ENDOTHELIAL CELLS; FEMALE; GLYCOPROTEINS; HINDLIMB; ISCHEMIA; MEMBRANE PROTEINS; MICE, KNOCKOUT; MICRORNAS; NEOVASCULARIZATION, PHYSIOLOGIC; PARACRINE COMMUNICATION; PEPTIDES; PROTO-ONCOGENE PROTEINS C-KIT; PTEN PHOSPHOHYDROLASE; STROMAL CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84922390408     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht041     Document Type: Article

References (25)

1. Nikol S, Huehns TY. Preclinical and clinical experience in vascular gene therapy: advantages over conservative/standard therapy. J Invasive Cardiol 2001;13: 333-338.
2. Takeshita S, Rossow ST, Kearney M, Zheng LP, Bauters C, Bunting S, Ferrara N, Symes JF, Isner JM. Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. Am J Pathol 1995;147:1649-1660.
3. Virag JI, Murry CE. Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. Am J Pathol 2003;163:2433-2440.
4. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T. Ischemia-And cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5:434-438.
5. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A, Sasaki K, Shimada T, Oike Y, Imaizumi T. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001;103:2776-2779.
6. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221-228.
7. Crosby JR, Kaminski WE, Schatteman G, Martin PJ, Raines EW, Seifert RA, Bowen-Pope DF. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res 2000;87:728-30.
8. Ambros V. The functions of animal microRNAs. Nature 2004;431:350-355.
9. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, Richardson JA, Bassel-Duby R, Olson EN. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 2008;15:261-271.
10. Poliseno L, Tuccoli A, Mariani L, Evangelista M, Citti L, Woods K, Mercatanti A, Hammond S, Rainaldi G. MicroRNAs modulate the angiogenic properties of HUVECs. Blood 2006;108:3068-3071.
11. Kuehbacher A, Urbich C, Zeiher AM, Dimmeler S. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res 2007;101:59-68.
12. Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ, Newman J, Bronson RT, Crowley D, Stone JR, Jaenisch R, Sharp PA, Jacks T. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 2008;132:875-886.
13. Tanzer A, Stadler PF. Molecular evolution of a microRNA cluster. J Mol Biol 2004; 339:327-335.
14. Kan T, Sato F, Ito T, Matsumura N, David S, Cheng Y, Agarwal R, Paun BC, Jin Z, Olaru AV, Selaru FM, Hamilton JP, Yang J, Abraham JM, Mori Y, Meltzer SJ. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 2009;136:1689-1700.
15. Li Y, Tan W, Neo TW, Aung MO, Wasser S, Lim SG, Tan TM. Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci 2009; 100:1234-1242.
16. Brett JO, Renault VM, Rafalski VA, Webb AE, Brunet A. The microRNA cluster miR-106b-25 regulates adult neural stem/progenitor cell proliferation and neuronal differentiation. Aging (Albany NY) 2011;3:108-124.
17. Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, Burchfield J, Fox H, Doebele C, Ohtani K, Chavakis E, Potente M, Tjwa M, Urbich C, Zeiher AM, Dimmeler S. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009;324:1710-1713.
18. Fang L, Deng Z, Shatseva T, Yang J, Peng C, Du WW, Yee AJ, Ang LC, He C, Shan SW, Yang BB. MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-beta8. Oncogene 2011;30:806-821.
19. Obernosterer G, Martinez J, Alenius M. Locked nucleic acid-based in situ detection of microRNAs in mouse tissue sections. Nat Protoc 2007;2:1508-1514.
20. Baker M, Robinson SD, Lechertier T, Barber PR, Tavora B, D'Amico G, Jones DT, Vojnovic B, Hodivala-Dilke K. Use of the mouse aortic ring assay to study angiogenesis. Nat Protoc 2012;7:89-104.
21. Poliseno L, Salmena L, Riccardi L, Fornari A, Song MS, Hobbs RM, Sportoletti P, Varmeh S, Egia A, Fedele G, Rameh L, Loda M, Pandolfi PP. Identification of the miR-106b-25 microRNA cluster as a proto-oncogenic PTEN-Targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal 2010;3: ra29.
22. Jiang J, Yamato E, Miyazaki J. Intravenous delivery of naked plasmid DNA for in vivo cytokine expression. Biochem Biophys Res Commun 2001;289:1088-1092.
23. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999;18:3964-3972.
24. Tian T, Nan KJ, Wang SH, Liang X, Lu CX, Guo H, Wang WJ, Ruan ZP. PTEN regulates angiogenesis and VEGF expression through phosphatase-dependent and-independent mechanisms in HepG2 cells. Carcinogenesis 2010;31: 1211-1219.
25. Noiseux N, Gnecchi M, Lopez-Ilasaca M, Zhang L, Solomon SD, Deb A, Dzau VJ, Pratt RE. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther 2006;14:840-850.